Pharmaceutical Commerce - November/December 2013

Academics lay into drug coupon programs in NEJM:

November 07, 2013

But their evidence validates, to a degree, industry's claim that coupons are not generics killers

Latest UPS Pain in the (Supply) Chain survey finds product security rising in attention

November 07, 2013

Regulatory compliance remains the top concern globally, but security and spoilage are high in the Asia/Pacific region

Promotional experimentation and consumer outreach will be available via the Truvio network

November 07, 2013

New service launched by WEGO Health offers rapid feedback from key opinion influencers in consumer healthcare

CVS Caremark opens a $67-million, 400-employee mail-order pharmacy in Illinois

November 07, 2013

Highly automated facility can process 50 million prescriptions annually for CVS Caremark's book of business

FedEx, IAG Cargo unveil new cold-chain capabilities

November 07, 2013

IAG Cargo's Heathrow facility is up and running; FedEx has begun construction of a facility at its Memphis hub

DME competitive bidding issues: When is enough enough?

November 05, 2013

Retailers, distributors and manufacturers are being affected by federal rules on durable medical equipment (DME)

Prime Therapeutics sets the parameters of specialty-drug purchasing discussions

November 05, 2013

Blue Cross/Blue Shield PBM says seven steps help manage costs

New products, services and businesses appear at Cold Chain Global Forum

November 05, 2013

Exhibition brings out the latest in temperature-controlled shipping

House passes Drug Quality and Security Act; Senate passage is likely

November 05, 2013

Bill includes voluntary oversight by FDA of outsourced compounded pharmaceuticals, national distributor licensure, and a timetable for serialization and drug tracking

Manufacturers should step up their monitoring of consumer healthcare choices under Obamacare

November 05, 2013

The Medicare Part D switchover of 2007 is only a partial proxy for what the healthcare system will experience in the next several years

As the clouds part on Physicians' Sunshine Act, doctors waffle between concern and indifference

November 05, 2013

Results of a survey panel by QPharma, presented at PDMA Sharing Conference, show a wide spread of reactions and concerns over agg-spend rules

FDA rules for unique device identification (UDI) of medical devices are finalized

November 05, 2013

UDIs will be in place starting in late 2014, and rolling out over the next four years thereafter

California governor vetoes biosimilar-unfriendly bill

November 05, 2013

While FDA dithers on regulatory guidance, state efforts to anticipate biosimilar regulation are mostly being rejected

Clinical trial logistics and packaging

November 04, 2013

The size of clinical trials continues to expand, observers say, creating a ripple effect in pharmaceutical packaging.

CSOs broaden their palette of service offerings

November 04, 2013

While riding the same downturn as overall pharma sales-rep headcount, contract sales organizations (CSOs) have invested in IT competency and marketing services to meet client needs

Recent US Supreme Court decisions narrow life-sciences patentability claims

November 04, 2013

Industry response may be to keep more innovations as trade secrets

The convergence of international and US pricing controls

October 31, 2013

New approaches, and new skill sets are necessary for meeting the challenges of global drug reimbursement policies

The right supply chain prescription

October 29, 2013

While pharma manufacturers may be concerned about the impact of item-level inventory tracking, it's an idea that actually makes great business sense